EASL Video Podcasts

The EASL Podcasts in video channel showcases educational episodes derived from the EASL Studio, the EASL DeepDive webinars and the EASL Policy Dialogues. Watch, listen to and stay abreast of the latest science and knowledge in Hepatology!

EASL Video Podcasts is a education podcast hosted by Unknown Host, with 41 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts EASL Video Podcasts, a education show with 41 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #36

  A joint EASL-ERN RARE-LIVER DeepDive – Wilson’s disease: a 2026 update

  Jul 3, 20261h 5m

  The following objectives will be addressed in this EASL Deep Dive episode: Have a profound knowledge of the pitfalls, limitations and difficulty of interpretation of the different tests of copper metabolism and liver copper assessments Be able to establish a diagnostic approach to Wilson’s disease, integrating clinical, laboratory, genetic and imaging tools Have a good understanding of the different treatment modalities, how to position them in the disease course, how to monitor treatment and what to expect as a result/outcome? This EASL DeepDive webinar is supported by Orphalan and Univar Solutions. Orphalan and Univar Solutions have had no input into the content of this EASL DeepDive.

  ListenShow Notes
• 

  Episode #35

  EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on extrahepatic Cholangiocarcinoma (eCCA)

  Apr 23, 20261h 7mS0

  <p >In this EASL DeepDive webinar, the expert panel presents and explains the key studies behind the latest recommendations included in the EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma.</p> <p>Learning Objectives</p> To identify patients at risk for eCCA, and review the current tools and strategies for its surveillance, diagnosis, staging, and classification To define the optimal candidates for resection and liver transplantation, and discuss challenges in the surgical management of eCCA To discuss the role of systemic therapy in the management of eCCA across all disease stages (including neoadjuvant, adjuvant, and palliative settings) <p>...

  ListenShow Notes
• 

  Episode #34

  EASL DeepDive: Key Changes in the New EASL HBV Guidelines

  Apr 9, 20261h 16mS0

  <p>In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of hepatitis B virus infection, published in the "Journal of Hepatology" in 2025.</p> <p>Learning objectives</p> Understand the updated EASL recommendations for initiating and discontinuing antiviral therapy in chronic hepatitis B, including key differences with other HBV guidelines. Participants will be able to identify treatment indications and make informed decisions about when and how to stop antiviral therapy. Learn how to monitor patients with hepatitis B across different clinical scenarios, including those not on treatment, those receiving antiviral therapy...

  ListenShow Notes
• 

  Episode #33

  EASL DeepDive: EASL Clinical Practice Guidelines on the management of autoimmune hepatitis

  Apr 9, 20261h 19mS0

  <p>In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of autoimmune hepatitis, published in the "Journal of Hepatology" in 2025.</p> <p>Learning objectives</p> Select induction and maintenance treatment strategies aimed at achieving complete biochemical response Recognise and manage disease flares, treatment intolerance, and suboptimal response in autoimmune hepatitis Understand tailored approaches to autoimmune hepatitis management in specific patient groups <p>Faculty</p> Mária Papp - Moderator Michael Heneghan - Speaker George Dalekos - Speaker Maria Carlota Londoño - Speaker

  ListenShow Notes
• 

  Episode #32

  EASL DeepDive: The Pursuit of a Cure: HCC Management Strategies

  Apr 9, 20261h 15mS0

  <p>Hepatocellular carcinoma (HCC) is responsible for 75% of all primary liver cancers and is the third most prevalent cause of cancer death worldwide, with 900,000 new cases diagnosed each year. Many patients are diagnosed at an advanced stage, making curative treatment difficult.</p> <p>In this DeepDive Webinar, you’ll be guided through the latest advances in hepatocellular carcinoma management, from the rising impact of immunotherapy combinations to evolving approaches in intermediate-stage disease. </p> <p>This EASL DeepDive webinar is supported by Bayer AG. Bayer AG has had no input into the content of this EASL DeepDive.</p> <p>Learning Objectives</p> ...

  ListenShow Notes

Recent guests on EASL Video Podcasts. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.